SalioGen Therapeutics rallies $115m Series B
SalioGen Therapeutics, a biotechnology company, has raised $115 million in Series B financing.
SalioGen Therapeutics, a biotechnology company, has raised $115 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination